To investigate the influence of alcohol intake on tumor growth of hepatocellular carcinoma (HCC) in patients with type C cirrhosis, we examined the tumor volume doubling time (TVDT) of 35 nodules from 35 cases ofHCC, calculated through ultrasonographic imaging. The patients were divided into two groups according to their drinking habit; 21 habitual drinkers (alcohol group; 80g ethanol/day for 5 years), and 14 patients without alcohol abuse (non alcoholic group). The average value ofTVDTin the alcoholic group was 78±47 days, although that of the non alcoholic group was 142±60 days. A statistically significant difference (p<0.01) was found between the two groups. Of the 21 habitual alcohol drinkers, 8 refrained from drinking after detection of HCC;their TVDT was about 30 days shorter than those whocontinued alcohol intake. In conclusion we found that alcohol intake was closely related to the tumor growth of HCCin patients with type C cirrhosis. (Internal Medicine 35: 443-448, 1996) 
Introduction
An incidence ofhepatocellular carcinoma (HCC) in patients with cirrhosis has been found to occur at a rate of 7%per year in Japan (1) . HCCassociated with hepatitis C virus (HCV) has recently been increasing in Japan, although the incidence rate of hepatitis B virus (HBV) associated HCCremains unchanged (2, 3) .
HCCwith type C cirrhosis has been reported to develop more frequently in habitual drinkers (4) . Alcohol abuse may have some effects on HCCdevelopments in type C cirrhosis (5, 6) . Several studies (7-1 1) discussing the tumor growth ofHCC have been reported. However,there have been no reports on the relationship between alcohol consumption and tumor growth of HCCwith type C cirrhosis. The purpose of this study was to identify the effect of alcohol intake on tumor growth of HCC with type C cirrhosis.
Subjects and Methods
Pa tients Thirty-five male patients with HCCcomplicating type C cirrhosis were selected from over 200 patients with HCC investigated between January 1 990 and May 1993 in Yamagata University Hospital, Yamagata, Japan. Thirty-five cases met the following criteria: (a) largest diameter of the HCCnodules was 5 cm or smaller and tumor margins were clearly identifiable on ultrasonographic (US) examination, (b) no treatment for HCC during the observation period, (c) two or more US examinations were performed over at least 2 mo, and (d) absence of symptomsrelated to HCC.Theseries included 35 men, ranging in age from 42 to 74 years (mean+SD, 63.2+7.6 year). These 35 patients did not receive treatment during the observation period due to the following reasons: refusal of treatment (n=15), severe functional repairment of the liver (n=5), presence of other diseases (n=7), and waiting time to admission (n=8). Amongthe 1 5 patients who refused treatment in 1 1 was because they lacked symptoms, and 4 were reluctant to submit to anti-cancer treatment.
Most patients had an underlying cirrhosis; they already had cirrhosis at the start of follow-up. HCCwere found by periodic US screening and surveillance of serum alpha-fetoprotein (AFP), because our policy for early detection of HCChas been to follow cirrhotic patients regularly with USexaminations and AFPmeasurement. In a few patients, HCCand cirrhosis were discovered incidentally by US and computed tomography. intake of at least 80 g ethanol daily for at least 5 years. In a further division of the alcoholic group, 13 patients who had been drinking after diagnosis of HCCbelonged to the Continued alcohol group and 8 patients who refrained from drinking during the observation were termed Stopped alcohol group. Table 1 summarizes the profiles and data of35 patients at the time of tumor detection. Nostatistically significant difference was seen between the alcoholic group and the non alcoholic group apart from the value of y-GTP (p<0.01). The severity of cirrhosis was assessed in these patients according to Child's classification. In the alcoholic group 7 patients (33.3%) were Child' s A, 5 patients (23.8%) Child' s B, and9 patients (42.9%) Child's C. In the non alcoholic group 5 patients (35.7%) were Child's C.
The details of features of 21 patients in the alcoholic group are listed in Table 2 . Total consumption of alcohol intake ranged from 351 to 1,679 kg, the average value was 762±292 kg; 703±23 1 kg in the continued alcoholic group and 858±366 kg in the stopped alcoholic group. In the continued alcohol group all the patients had been drinking after detected out of HCCduring USobservation period. The total alcoholic consumption ranged 4.4 to 28.8 kg and the average was 13.1±8.6
kg during the period.
Follow-up and assessment of tumor growth
The tumor growth rate was obtained by measuring the tumor volume doubling time (TVDT), which was calculated by the following formula proposed by Schwartz (1 2) and Gerstenberg (13) and based on the hypothesis of Collins et al (14) :
where t is the time of the observation period, Dl and DOare the tumor diameter at the end and beginning of the time interval respectively. Tumor size was assessed from the ultrasonic image; subsequent measurementsof changes in size were based on US images. US was performed with a 3.5 MHzconvex type transducer (SSD 650, ALOKATokyo, Japan). In the case of 
Results
Comparison of the TVDT TVDTof the alcoholic group ranged from 22 to 17 1 days; the average value was 78±47 days. That of the non alcoholic group ranged from 53 to 262; the average value 142±60 days. There was a statistically significant difference (p<0.01) between the TVDTof the two groups (Fig. 2) . TVDTof the stopped alcohol group ranged from 52 to 126; with an average value of 98+42 days. That of the continued alcoholic group ranged from 22 to 123 days; with an average value of 65±44 days. Although the difference was less statistically significant between the stopped alcohol group and the continued alcohol group (Fig. 3) , there was a tendency for the TVDTof the continued alcohol intake group to be shorter.
Relationship between the TVDTand clinical variables There was no relationship between the TVDT and the total alcohol consumption, age, Child's classification, initial tumor diameter, numberof nodules, ultrasonographic pattern, and histological type (Table 3) 
Discussion
There have been several studies (7-ll) of the growth of HCCin previously untreated patients, however there is some difference in the TVDTamong these literatures. In these literatures, the TVDTwas reported for 102 days in the series of Okazakietal (8), 136daysbySheuetal (10), 195 daysbyEbara etal (1 1), and204 daysbyBarbaraetal (9) . Inthepresentstudy, the average of the TVDTin 35 patients was 104 days. In these literatures, the measurementof the TVDT was samemethod which used the formula developed by Schwartz (12) , and the tumor size was measured via ultrasonographical findings. As the same method was used in these reports, the difference in the TVDTmaybe attributable to the selection of the subjects.
In those reports several etiologies ofbasal liver disease was included, where 84% were positive for HBs Ag in the series of Sheu et al (10) and 13-28% in the other series (7-9, ll), while HCCwith only type C cirrhosis was investigated in this study. HBVis an important factor in the development of HCC (15), and particularly, the mechanism by which HBVcontributes to the pathogenesis of HCCintegration of HBVgenomic DNAof hepatocytes. However, the mechanism of HCCin HCVinfection has not been clarified yet. HCVis an RNAvirus and is not reverse transcribed, hence it is not integrated into the host genome. These differences may suggest certain differences existing in the growth pattern ofHCC between HBVand HCV associated with HCC.Encapsulation of the tumor with an expanding growth pattern was more frequent, and infiltrating growth was less commonin non A, non-B than in HBV associated with HCC(16).
In a recent study (17), the long-term survival rate was significantly better in females than in males. Therefore, in the present study weexcluded female cases. Other literatures on the TVDT included both male and female cases. There was no significant difference in the TVDTof this study between elderly patients and younger patients. Although it has been reported that the tumor growth slows with age in human breast cancer (1 8), there have been no such reports in human HCCexcept for the report of Okada et al (19) . Their subjects were cases of recurrent HCC,and the difference in the TVDTmay be between primary, intrahepatic and multicentric nodules. Okazaki et al (8) and Barbara et al (9) reported that the TVDTwas not statistically significantly correlated with histopathological findings, as was found in our study. The difference in the TVDT of the reports maybe due to the differences in subjects because the patients in those reports had several factors that seemed difficult to compare. It may be necessary to place subjects in categorical groups for better comparisons, accordingly our subjects were male patients with type C cirrhosis. There was no significant statistically difference in the TVDT between the two groups which classified according to the tumor size of20 mmin the present study. A current study (20) revealed that nodules of less than 20 mmmarkedly improved the survival rate by early therapy, consequently the size of 20 mmwas used for the classification in this study. Only Sheu et al (10) reported that the TVDTwas positively correlated with the initial tumor diameter. There was no relationship between tumor size and the TVDTin other reports (7-1 1 , 19 (24) suggested that the inhibition of liver regeneration by alcohol may cause a decreased capacity for repair; this decrease thereby could accelerate the progress of liver damage caused by the virus, and such damagemayworsen the prognosis and accelerate carcinogenesis in the liver. However, there has been no report concerning the relationship between alcohol abuse and tumor growth ofHCC.Our results suggest that alcohol abuse is related to tumor growth in addition to HCCdevelopment. During the process in carcinogenesis and tumor progression, p53 gene mutation is thought to be a late event in several human cancers (25) and in human HCCmost of the p53 mutation and loss of heterozygosity were observed in moderately and poorly differentiated HCC(26). Hayashi et al (27) reported that p53 mutations are associated with tumor progression as a late event in hepatocarcinogenesis. Heavy drinking correlates with p53 gene mutations in squamouscell carcinoma of the head and neck (28). As for HCC, it may be speculated that specific p53 mutations are associated with HCCpatients who are heavy alcohol abusers. Moreepidemiological and molecular studies are necessary to confirm that the present results implicate a negative effect of alcohol on tumor growth of HCCwith type C cirrhosis.
In conclusion, in patients with HCCcomplicated type C cirrhosis, we found that alcohol intake was closely related to the tumor growth of HCC.More periodic US screening of patients with type C cirrhosis according to their alcohol intake is suggested. Abstention from drinking may be recommended in cases of detected type C hepatitis to improve the prognosis.
